Common initial side effects may include: Importantly, side effects tend to improve over time with continued use
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, is not detected by standard urine drug screening panels
Social support counts, so get involved in groups or see a therapist
FDA Warning: RISK FOR ILEUS (INTESTINAL BLOCKAGE) (FDA 09/22/2023) Amongst more than 8,500 voluntary reports of GI disorders associated with the use of semaglutide reported through June 30, 2023, ileus was included in 33 cases, and two cases of death
Reader support is helping shape the future of local news
To manage this, focus on high-protein meals and fiber-rich vegetables